Goodwin advised Aptinyx on the deal Aptinyx Inc. finalized its $70 million Series B financing to fund the advancement of its expanding clinical stage pipeline. The…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
